Delivery Order SPE2DU25D9439-SPE2DU26FEEFN
- Not listed
- The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 7, 2026, with a ceiling value of $2,370.92 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, with a ceiling value of $1,931.83 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $8,844.32 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic...
- The Defense Logistics Agency issued a $7,594.65 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $3,320.62 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to Department of Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. The order ceiling is $1,017.13 and carries a firm fixed price. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing DLA to issue delivery orders for pharmaceutical products including branded...
- The Defense Logistics Agency issued a $5,672.13 delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract supporting recurring pharmaceutical supply needs for Department of Defense military healthcare facilities worldwide. The parent contract, designated SPE2DR,...
- The Defense Logistics Agency issued a $65,779.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables...
- The Defense Logistics Agency issued a $2,494.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL. DMS...
- SPE2DU25D9439Indefinite Delivery Contract
- SPE2DU25D9439-SPE2DU26FEEFNDelivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $8,431.61 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The ultimate completion date for this order is February 11, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 2/9/26 |